Evanston, IL · Founded 2022 · Privately Held (backing)
Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering. Syenex is based in Evanston, IL and was founded in 2022. It was valued at $22 million at its seed round in Jan 2025, the last priced event on record. It has raised $13.7 million across 2 recorded rounds; the latest was an $8.7 million early-stage round in Jan 2025.
PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$13.7M
Last round
Early Stage VC
Jan 2025
Team — not yet on record
No current team members for Syenex are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Syenex with a free account
·Watch Syenex: the Monday email on marks, rounds and moves
